Discover 602 paid clinical trials in Omaha, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Omaha hosts numerous active clinical trials targeting diseases such as cancer, asthma, and autoimmune disorders like lupus. The city’s leading research institutions are recruiting participants, both as a healthy volunteer and those looking for studies related to specific health conditions, offering opportunities to take part in groundbreaking research and access innovative treatments.
Filter
2
Filter results
Results: 602
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Omaha NE, Des Moines IA, Sioux Falls SD, Kansas City MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT04684368
Phase2, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Omaha NE, Des Moines IA, Sioux Falls SD, Kansas City MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 30
Code: NCT06172296
Phase3, Recruiting
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Omaha NE, Iowa City IA, Rochester MN, Maywood IL,
Sponsor: CorMedix Therapeutics
Sex: All
Age: 12+
Code: NCT06822426
Phase3, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Omaha NE, Des Moines IA, Sioux Falls SD, Kansas City MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase3, Recruiting
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
for
Locoregional Recurrence,
Location: Omaha NE, Iowa City IA, Madison WI, Chicago IL,
Sponsor: Oana Danciu
Sex: All
Age: 18+
Code: NCT05467891
Phase2, Recruiting
MOTION Clinical Trial
for
Osteoarthritis, Knee
Location: Omaha NE, Oak Brook IL, Chicago IL, Columbus OH,
Sponsor: Moximed
Sex: All
Age: 0+
Code: NCT06843980
Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis